Table 2 |
|
Three altered bio-systems in CFS |
|
Oxidative Stress Genes |
|
|
|
Up-regulated |
|
Prostaglandin Synthase: COX-1 and 2, haemoglobin gamma A and gamma G |
|
Down-regulated |
|
Glutathion-s-transferase |
|
|
|
Apoptosis Genes: Up-regulated |
|
|
|
Annexin -A3, -A5, Serine/threonine kinase 17b, Histones 1&2, Protein S (alpha), Serum deprivation response (Phosphatidylserine binding protein) Caspase 1, TGFβ1 Death effector filament forming CED4-like apoptosis protein, Complement 3a receptor 1, Early growth response 1, TNF-A1P3, -RSF17, -SF4 |
|
|
|
Immune Dysfunction Genes (including markers of viral immuno-modulation/evasion) |
|
|
|
Up-regulated |
|
DAF (CD55) & CD46 |
|
Antigen processing via MHC class II (MHC II DP α1 and DR α) |
|
IL-12, IL-13 & IL-6 biosynthesis |
|
Down-regulated: The MHC-1 system including: |
|
Natural Killer cell receptors (KIR) |
|
TCR complex (T-cell receptors α, β, δ, γ) |
|
NO production (up-regulation of arginase I & II) |
|
Flavohaemoprotein B5 Leukocyte-derived arginine aminopeptidase (L-rap) |
|
|
|
Gow et al. BMC Medical Genomics 2009 2:38 doi:10.1186/1755-8794-2-38 |